The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa by Silva, Sónia Carina et al.
The role of secreted aspartyl proteinases in Candida tropicalis invasion
and damage of oral mucosa
S. Silva1, S. J. Hooper2, M. Henriques1, R. Oliveira1, J. Azeredo1 and D. W. Williams2
1) Institute for Biotechnology and Bioengineering, Universidade do Minho, Campus de Gualtar, Braga, Portugal and 2) Tissue Engineering & Reparative
Dentistry, School of Dentistry, Heath Park, Cardiff, UK
Abstract
Candida virulence attributes include the ability to colonize and invade host tissues, and the secretion of hydrolytic enzymes. Although
Candida albicans is regarded as the principal fungi causing infections in humans, other species, particularly Candida tropicalis, are increas-
ingly being recognized as human pathogens. Relatively little is known, however, about the virulence attributes associated with C. tropical-
is. The present study aimed to investigate epithelial infection by C. tropicalis using a reconstituted human oral epithelium (RHOE)
together with confocal laser scanning microscopy and real-time PCR. A comparison of clinical strains was made in terms of tissue colo-
nization, invasion and C. tropicalis secreted aspartyl proteinase (SAPT) gene expression. All C. tropicalis strains were able to colonize
RHOE in a strain-dependent manner. After 12 h of infection, C. tropicalis was found to be highly invasive, with extensive tissue damage
occurring after 24 h. Real-time PCR of C. tropicalis SAPT1-4 genes showed that expression was strain-dependent, with SAPT2-4 tran-
scripts being frequently detected and SAPT1 rarely detected. Tissue invasion and damage was not inhibited by the presence of pepstatin
A. Accordingly, and given that an increase in infection time was not accompanied with an increase in SAPT gene expression, it can be
suggested that the proteinases are not involved in invasion and damage of RHOE by C. tropicalis. In summary, C. tropicalis can be consid-
ered as highly invasive with the ability to induce significant tissue damage. These features, however, do not appear to be related to spe-
cific SAPT gene expression.
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Introduction
Many Candida species inhabit human mucosal surfaces as
harmless commensals. However, these organisms can cause
opportunistic infections (candidosis), especially in compro-
mised patients such as those individuals with HIV-infection
and diabetes mellitus, and well as in those receiving steroid,
broad-spectrum antibiotic and cytotoxic drug therapy [1].
Candida albicans is regarded as the most prevalent species
involved in both human colonization and infection [2,3]. Nev-
ertheless, other Candida species are increasingly recognized
as important agents of human infection [3–7]. This may
reflect the higher level of resistance often exhibited by these
species to certain antifungal agents [8] or an association with
modern drug therapies, including the more widespread use
of immunosuppressive agents and broad-spectrum antibiotics.
Candida tropicalis is a species that is now recognized as an
important pathogen of debilitated individuals [9–11]. How-
ever, when compared with the more extensively studied
C. albicans [12–16], relatively less is known about C. tropicalis
and its ability to cause human disease [17–22]. Thus, a
greater understanding of the virulence determinants of this
species is important because not only would this provide an
insight into its pathogenic mechanisms, but also it might
promote the development of more effective treatment
strategies.
Virulence attributes of Candida species include the ability
to adhere to host tissue, exhibit morphological alteration
and secrete hydrolytic enzymes [e.g. phospholipases and
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secreted aspartyl proteinases (SAPs)] [23]. The change from
a commensal to a pathogen has been related to altered
expression of these virulence factors together with a debili-
tation in host defence mechanisms. Moreover, SAPs are con-
sidered to be key enzymes that contribute to candidal
infection by promoting damage to the host mucosa, thereby
facilitating the invasion of the organism into the epithelium
[20,24,25]. Furthermore, it is known that C. tropicalis pos-
sesses at least four genes encoding SAPs, and these are des-
ignated SAPT1 to SAPT4 [20,26].
The pathogenesis of mucosal candidosis has been investi-
gated in several studies using animal models, primarily with
C. albicans [13,27]. In recent years, a commercially available
reconstituted human oral epithelium (RHOE) has successfully
been used to study the in vitro mechanisms of tissue invasion
by C. albicans [12,14,15,25,28–30]. Thus, the present study
aimed to investigate the pattern of colonization and invasion
of RHOE by C. tropicalis and to relate it to SAPs expression.
Specifically, a comparison of clinical strains obtained from dif-
ferent body sites was made in terms of tissue colonization,
invasion and SAP gene expression using the RHOE model,
together with confocal laser scanning microscopy (CLSM)
and real-time PCR.
Materials and Methods
C. tropicalis strains
A total of six clinical isolates of C. tropicalis, originally recov-
ered from the oral cavity (strains AG1 and T2.2), vagina
(strains 12 and 75) and urinary tract (strains 519468 and
544123), were used in the present study. A reference strain of
C. tropicalis from the American Type Culture Collection
(ATCC 750T) was also used. Oral isolates were originally
obtained from patients attending the ‘Clı´nica dos Congrega-
dos’ (Braga, Portugal) and the strains isolated from urinary
tract infections were obtained from the ‘Hospital de Sa˜o Mar-
cos’ fungal collection (Braga, Portugal). C. tropicalis strains 12
and 75 (recovered from the vaginal tract) were provided by
the University of Maringa´ (Maringa´, Brazil). The identification
of all isolates was confirmed by PCR-based sequencing using
specific primers (ITS1 and ITS4) for the 5.8S subunit gene [31].
Isolates were initially cultured on Sabouraud Dextrose
Agar (SDA; Merck, Darmstadt, Germany) for 48 h at 37C,
followed by culture in yeast nitrogen base medium (BD
Diagnostics, Cowley, UK), supplemented with 0.5% glucose
(w/v), for 12 h at 37C. After incubation, cells were
harvested by centrifugation and washed three times with
phosphate-buffered saline (PBS; pH 7). The yeast cells were
then counted using an Improved Neubauer haemocytometer
(Marienfield, Lauda-Ko¨nigshofen, Germany) and adjusted to a
concentration of 2 · 106 cells/mL.
In vitro RHOE infection model
Tissue inserts (0.5 cm2) of commercially available (SkinEthic
Laboratories, Nice, France) human oral epithelium, derived
from a squamous carcinoma of the buccal mucosa (human
keratinocyte cell line TR 146) and formed on a support
membrane, were placed in a new 24-well tissue culture plate.
Standardized suspensions of C. tropicalis (1 mL containing
2 · 106 cells in MCDB-153 defined medium (Clonetics, San
Diego, CA, USA) containing 5 mg/L insulin, 1.5 mM CaCl2,
25 lL/mL gentamicin and 0.4 mg/L hydrocortisone) were
then added to each RHOE tissue insert. Control samples
were inoculated with 1 mL of medium devoid of Candida
cells. Tissues were subsequently incubated at 37C in a 5%
CO2 environment with saturated humidity for 12 and 24 h.
In addition, planktonic cultures of C. tropicalis, used as con-
trols, were prepared using the same tissue culture medium
and incubation conditions, but in the absence of RHOE.
These planktonic cultures were subsequently used for stan-
dardizing lactate dehydrogenase (LDH) activity and also as
controls for SAP gene expression studies (24 h).
After incubation, the tissues were rinsed twice with PBS
to remove non-adherent Candida cells and then bisected,
with one-half used for CLSM analysis and the other for RNA
extraction and real-time PCR studies. The culture medium
was also analyzed for Candida induced damage using a LDH
assay.
In separate experiments, the SAP inhibitor, pepstatin A
(Sigma, Poole, UK) was added, simultaneously with the
C. tropicalis inoculum, to the tissue inserts to assess the effect
of SAPs on the infection process. Briefly, pepstatin A was
dissolved in 100% methanol and added directly to the pre-
pared Candida inoculum to achieve a final concentration of
pepstatin A of 15 mg/L. These tissue inserts were examined
after 24 h for invasion of Candida and LDH production.
CLSM
Colonization and morphological characteristics of C. tropicalis
on the surface of fresh tissues were assessed using CLSM,
following direct labelling of Candida cells with 100 lL of con-
canavalin A lectin conjugated with Alexa 594 (Molecular
Probes-Invitrogen, Paisley, UK: 25 mg/L in PBS) for 20 min at
room temperature. Briefly, infected tissue was fixed in 2%
(v/v) paraformaldehyde (in ultrapure water) for 24 h at 4C
and embedded in paraffin wax using standard histological
techniques. Tissue sections (20 lm) were cut and placed on
Histobond+ coated microscope slides (Raymond A Lamb,
Eastbourne, UK), de-waxed by processing through xylene,
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followed by immersion in ethanol and then water. The pre-
pared sections were overlaid with 50 lL of Alexa 594-conju-
gated concanavalin A lectin (Molecular Probes-Invitrogen;
25 mg/L in PBS) for 20 min at room temperature. For kerati-
nocyte nuclear staining within the RHOE sections, Hoechst
33258 dye (Sigma; 1 mg/L) was applied for 30 min at room
temperature and then washed with PBS. Tissues were
mounted in Vectashield (Vector Laboratories, Peterborough,
UK) fade-retarding mountant and then observed by CLSM
using a Leica TCS SP2 AOBS spectral confocal microscope
(Leica, Wetzlar, Germany). The sections were scanned
through full depth using appropriate settings for single- and
double-fluorescence recordings of Hoechst 33258 (laser
excitation line 485 nm and emissions detected 410–485 nm)
and Alexa 594-conjugated concanavalin A (laser excitation
line 546 and emissions detected 600–660).
LDH assay
The release of LDH from the RHOE into the culture med-
ium was used as a measure of epithelial cell damage. The
LDH concentration in the medium from both control and
infected tissues was measured at 12 and 24 h (in both pres-
ence and absence of pepstatin A) using the CytoTox-ONE
kit (Promega, Madison, WI, USA) in accordance with the
manufacturer’s instructions. A control for LDH activity was
also prepared using a replicate preparation of Candida, cul-
tured in medium devoid of RHOE. The LDH activity of this
control was subtracted from the LDH activity of the tissue
infected with yeast. The LDH released during infection with
the different C. tropicalis strains was then expressed as a rela-
tive activity determined against the untreated control tissue.
All experiments were performed in duplicate.
Analysis of SAP gene expression
RNA extraction. Tissues for RNA extraction were stored at
4C in 2 mL microtubes containing RNAlater solution
(Ambion, Huntington, UK). Prior to RNA extraction, lysis
buffer was prepared by adding 10 lL of b-mercaptoethanol
per mL of RLT buffer (Qiagen, Crawley, UK). Then, 600 lL
of lysis buffer and glass beads (0.5 mm diameter, approxi-
mately 500 lL) were added to each tissue and these were
homogenized twice for 30 s, using a Mini-BeadBeater-8 (Stra-
tech Scientific, Soham, UK). After tissue disruption, the
RNeasy Mini kit (Qiagen) was used for total RNA extraction
according to the manufacturer’s recommended protocol.
Potential DNA contamination was removed by RNase-Free
DNase I (Qiagen) treatment. Additionally, RNA was also
extracted, following the same approach, from C. tropicalis
planktonic cells (absence of RHOE) prepared and cultured in
the same manner as the RHOE-infecting strains.
Primer design. Primers for real-time PCR were designed
using the PRIMER3 web-based software (http://frodo.wi.mit.
edu/primer3) and these primer sequences are listed in
Table 1. To verify the specificity of each primer pair for its
corresponding target gene, PCR products were first
amplified from ATCC 750T genomic DNA. Control S14
primers were also used [32] to detect human recombinant
DNA.
Synthesis of cDNA. From each sample, 10 lL of extracted
RNA was used for cDNA synthesis. First, the RNA was
incubated with 5 lL (50 mg/L) of oligo-dT primer (Promega,
Southampton, UK) at 70C for 5 min. Subsequently, RNA
was added to a reaction mixture containing RT Buffer
[50 mM Tris (pH 8.3), 3 mM MgCl2, 10 U of RNasin Plus
RNase inhibitor (Promega)], 20 lM of each deoxynucleoside
triphosphate and 200 U of Moloney murine leukaemia virus-
reverse transcriptase (Promega), in a final reaction volume
of 50 lL. cDNA synthesis was then performed at 42C for
1 h. The reaction was stopped by heating for 5 min at
95C.
Real-time PCR. Real-time PCR was used to determine the
relative levels of SAPT1-4 mRNA transcripts in the RNA sam-
ples, with ACT1 used as a reference housekeeping gene. A
7900HT Fast Real-Time PCR System (Applied Biosystems,
Warrington, UK) was used in accordance with the manufac-
turer’s instructions. Each reaction mixture consisted of the
working concentration of Power SYBR Green PCR master
mix (Applied Biosystems), 300 nM forward and reverse pri-
mer and 1 lL of cDNA, in a final reaction volume of 20 lL.
Negative (water) controls were included in each run. The
relative quantification of SAPT1-4 gene expression was per-
formed by the DCT method, using the control gene (ACT1)
to normalize the data. Each reaction was performed in tripli-
TABLE 1. Primers used for real time-PCR analysis of SAP
and control gene expression
Sequence (5¢ to 3¢) Primer Target
PCR
product
size (bp)
GGAAGATCTGATGTGCCAACTACATTGA Forward SAPT1 1005
CGTGCGGCCGCTCTACAAAGCCGAGATGT
CT
Reverse
TTCTTCTAGTGGTACCTGGGTCAAAG Forward SAPT2 762
CATAGATCTCTAAACAATAGTGACATTAGA Reverse
ACTTGGATTTCCAGCGAAGA Forward SAPT3 165
AGCCCTTCCAATGCCTAAAT Reverse
GTACTCGAGCTCCTACAACTTCACCTCCT Forward SAPT4 1130
CATGGATCCCTATGTAAGTGGAAGTATGTT Reverse
GACCGAAGCTCCAATGAATC Forward ACT1 181
AATTGGGACAACGTGGGTAA Reverse
CAGGTCCAGGGGTCTTGGTCC Forward Human
GGCAGACCGAGATGAATCCTCA Reverse S14 143
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cate and mean values of relative expression were analyzed
for each SAP gene.
Statistical analysis
Results were compared using one-way analysis of variance by
applying Levene¢s test of homogeneity of variance and
Tukey’s multiple-comparisons test, using SPSS (SPSS Inc.,
Chicago, IL, USA). All tests were performed with a 95% CI.
Results
In vitro RHOE infection
Fresh RHOE tissues were used to study surface coloniza-
tion and candidal morphology after 12 h of incubation
(Fig. 1 and Table 2). The results showed that all C. tropicalis
strains were able to colonize the RHOE. However, the
extent of colonization was strain-dependent. By contrast to
the other C. tropicalis strains, strain 544123 (urinary tract
isolate) exhibited a low colonization level. Interestingly, the
different C. tropicalis strains exhibited diverse and strain-
dependent differences with respect to cell morphologies on
the RHOE surface (Fig. 1 and Table 2). C. tropicalis T2.2 and
AG1 (oral strains) and C. tropicalis 12 (vaginal strain) formed
a network of both yeast and filamentous morphology. This
contrasted with C. tropicalis 519468 (urinary isolate) and
C. tropicalis ATCC 750T, with both exhibiting predominantly
filamentous growth on the RHOE surface. C. tropicalis 75
(vaginal isolate) and C. tropicalis 544123 (urinary tract)
strains colonized and grew on the RHOE primarily in yeast
form.
To assess the invasive capability of C. tropicalis, the RHOE
tissues were fixed, sectioned, stained and observed by
CLSM at 12 and 24 h after infection (Figs 2 and 3 and
Table 2). Fig. 2, illustrates the ability of C. tropicalis to invade
the RHOE after 12 h of incubation. All C. tropicalis strains
extensively invaded the RHOE, with the exception of
C. tropicalis 544123 (urinary isolate) that only presented
clusters of yeast attached to the tissue surface. Invasion was
more extensive after 24 h of infection (Fig. 3) and disrup-
tion of the epithelial structure was also more evident. Infec-
tion with C. tropicalis AG1 and T2.2 (both oral isolates) and
C. tropicalis 12 (vaginal isolate) induced vacuolization
between keratinocytes, promoting a high level of disorgani-
zation of the epithelium structure. Tissue alteration caused
by C. tropicalis 75 (vaginal isolate) and C. tropicalis 519468
(urinary isolate) resulted in the detachment of the superfi-
cial keratinocytes layer. Furthermore, the high number of
filamentous forms of both strains appeared to be responsi-
ble for the detachment of the RHOE from the support
membrane. By contrast, changes caused by the non-invasive
C. tropicalis 544123 (urinary isolate) and by C. tropicalis
ATCC 750T were limited, despite the latter being able to
invade the RHOE.
To quantify tissue damage, the levels of released LDH
were determined after 12 and 24 h of infection (Fig. 4). Co-
culture of tissue with each of the isolates caused a moderate
increase in the LDH levels after 12 h of incubation com-
pared to uninfected controls. Furthermore, the relative LDH
activity was similar for all C. tropicalis strains analyzed
(p >0.05). The levels of LDH markedly increased (approxi-
mately five-fold) with longer infection time (p >0.05). The
results obtained for LDH activity (Fig. 4) positively corre-
lated with the extent of tissue damage observed microscopi-
cally (Fig. 3). C. tropicalis 544123 caused the least
histologically observed damage (not invasive) and also pro-
duced the lowest LDH levels, although this was still signifi-
cantly higher than the uninfected control tissue (Fig. 4 and
Table 2).
To provide insight into the mechanism of C. tropicalis
RHOE invasion and induction of tissue damage, the effect of
the specific aspartyl proteinase inhibitor, pepstatin A on the
infection process was evaluated (Figs 4 and 5). Importantly,
invasion of C. tropicalis was not inhibited by the presence of
pepstatin A (Fig. 5). Furthermore, the inclusion of pepstatin
A did not reduce the level of tissue damage as assessed his-
TABLE 2. Candida tropicalis infection profile of reconstituted human oral epithelium (at 12 and 24 h) as assessed by confocal
laser scanning microscopy
Candida tropicalis
strains Origin
Surface
colonization (12 h)
Strain morphology in presence
of tissue (12 h)
Invasion/integrity of RHOE
12 h 24 h
AG1 Oral +++ Yeast and filament forms High/undamaged High/damage
T2.2 +++ Yeast and filament forms High/undamaged High/damage
519468 Urinary +++ Predominantly filament forms High/undamaged High/damage
544123 + Predominantly yeast Low/undamaged Low/undamaged
12 Vaginal ++ Yeast and filament forms High/undamaged High/damage
75 ++ Predominantly yeast High/undamaged High/damaged
ATCC 750T Reference +++ Predominantly filament forms High/undamaged High/undamaged
CMI Silva et al. Candida tropicalis infection of oral mucosa 267
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 264–272
tologically (Fig. 5) and by LDH activity (Fig. 4). At the con-
centrations used, pepstatin A did not affect C. tropicalis colo-
nization or the appearance of the uninfected RHOE.
SAP gene expression
Table 3 presents the mean percentage SAP gene expression
levels relative to ACT1, for C. tropicalis infecting RHOE for 12
and 24 h, and for planktonic cells (after 24 h of incubation
using the same conditions, but in the absence of RHOE).
Real-time PCR analysis revealed a wide range of expres-
sion profiles of SAP genes for the seven C. tropicalis strains in
the three conditions examined (Table 3). In general, SAPT2-4
transcripts were frequently detected, whereas SAPT1 was
only rarely detected. After 12 and 24 h of incubation, C. trop-
icalis strains exhibited different SAPT2-4 gene expression pro-
files. An increase in the expression of SAP genes with a
longer incubation time was only evident with C. tropicalis
ATCC 750T and C. tropicalis 75 (SAPT2-4), and for C. tropicalis
AG1, C. tropicalis T2.2 and C. tropicalis 544123 (SAPT3). Fur-
thermore, all C. tropicalis strains growing for 24 h in the
planktonic form expressed all the SAPT2-4 genes, with the
exception of SAPT2 for C. tropicalis 519468 and C. tropicalis
12. Additionally, there was an apparent increase in the
expression of most SAPT genes for planktonic cells (24 h)
compared to their 24 h RHOE counterparts. For example,
with the oral isolate C. tropicalis AG1, real-time PCR analysis
revealed an increased expression of SAPT3 and SAPT4 genes,
by approximately four- and 20-fold, respectively, compared
to RHOE-infecting cells.
Discussion
The pathogenesis of mucosal candidosis, particularly those
infections caused by C. albicans, has been investigated in sev-
eral studies [12,14–16,28–30] using RHOE as a successful sur-
rogate model to animals. C. tropicalis has been recognized as
an increasingly important pathogen of debilitated individuals
[9–11], with several studies demonstrating that C. tropicalis
virulence in mice can be similar to, or indeed higher than,
C. albicans [21,22]. However, compared to C. albicans, rela-
tively few investigations have been performed to assess the
virulence of C. tropicalis, particularly in human tissues
[14,33,34]. Thus, the primary aim of the present study was to
investigate the pattern of colonization and invasion of RHOE
by a variety of C. tropicalis strains from different body sites.
The results obtained (Fig. 1 and Table 2) showed that the
oral epithelium was successfully colonized by C. tropicalis,
although the extent of colonization was noticeably strain-
dependent. The study also revealed that C. tropicalis was able
10 µm 10 µm
10 µm10 µm
75 T2.2
519468544123
FIG. 1. Colonization profile of Candida
tropicalis strains infecting human oral epi-
thelium after 12 h of incubation. *Presence
of filamentous forms.
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to develop filamentous forms on the tissue surface that
could promote colonization. Furthermore, CLSM images
showed that, similar to C. albicans [14,15,34], C. tropicalis was
also able to invade the RHOE (Fig. 2). In this regard, invading
fungal elements were found to penetrate to the deepest
layers of the RHOE within just 12 h of infection (Fig. 2 and
Table 2). These observations are not in total agreement with
previous studies [14,33,34], where C. tropicalis has been
T2.2 544123
1275
10 µm 10 µm
10 µm 10 µm
FIG. 2. Confocal laser scanning micros-
copy images of Candida tropicalis strains
infecting human oral epithelium after
12 h of incubation.
AG1
T2.2
12 519468 Control
54412375
10 µm 10 µm 10 µm
10 µm10 µm10 µm
10 µm
FIG. 3. Confocal laser scanning microscopy images of Candida tropicalis strains infecting human oral epithelium after 24 h of incubation.
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described as a non-invasive species, despite having an ability
to colonize. However, as revealed in the present study,
strain differences in the capability to invade were apparent.
Subsequent examination of epithelial invasion revealed sig-
nificant differences between 12- and 24-h infection periods,
indicating progressive tissue damage related to the duration
of infection. There was induction of significant tissue disrup-
tion in the tissue structure (Fig. 3) compared to uninfected
tissues after 24 h infection. The degree of tissue damage was
further evaluated quantitatively through the measurement of
relative LDH activity (Fig. 4), and the results obtained posi-
tively correlated with the C. tropicalis infection temporal pat-
tern and histologically observed damage. Interestingly, after
12 h of infection, the LDH activities of tissues infected with
the different C. tropicalis strains were largely similar, implying
equivalent degrees of the damage caused. More pronounced
differences were found after 24 h of infection, which might
reflect a variation in the ability of strains to continue to
grow within the epithelium and induce damage after initial
invasion. These features were similar to those described in
previous studies [14,34], where it was demonstrated that
Candida dubliniensis, Candida glabrata, Candida parapsilosis, Can-
dida krusei and particularly C. tropicalis, were causative agents
of dramatic histopathological tissue alteration.
Of note, the six strains classified in the present study as
‘high invaders’ were derived from three different superficial
body sites, possibly indicating that strain origin is not impor-
tant with respect to invasive capability. However, further
studies involving a greater number of strains, including those
from systemic infections, would be of benefit in confirming
this view. One strain (C. tropicalis 544123) did not produce
extensive filamentous forms and, notably, this strain was the
only one that was unable to invade the oral epithelium
(Fig. 2 and Table 2). This result would support the view that
it is the filamentous forms that facilitate tissue invasion.
FIG. 4. Relative lactate dehydrogenase activity measured in the
human oral epithelium tissue culture supernatant after 12 h ( ) and
24 h ( ) incubation with different Candida tropicalis strains; and in
the presence of pepstatin A at 24 h (h). *Strain statistically different
from the other strains (p <0.05). Error bars represent the SD.
AG1 12 519468
ControlT2.2
10 µm 10 µm 10 µm
10 µm10 µm
FIG. 5. Confocal laser scanning microscopy images of Candida tropicalis strains infecting human oral epithelium after 24 h in presence of 15 lL/
mL pepstatin A.
270 Clinical Microbiology and Infection, Volume 17 Number 2, February 2011 CMI
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 264–272
SAPs are considered hydrolytic enzymes contributing to
Candida infection by promoting damage to the host mucosa,
thus facilitating invasion of the epithelium [20,24]. There are
at least four known genes encoding for SAPs in C. tropicalis
[16,20,26] and the expression of these C. tropicalis genes and
the role of SAPs in the infection process were assessed in
this present study. For all C. tropicalis strains, SAPT gene
expression was assessed using real-time PCR, after 12 and
24 h of infection (and after 24 h of incubation for equivalent
planktonic preparations). Overall, the expression of SAP
genes by C. tropicalis was strain-dependent, with SAPT1 not
expressed by the majority of strains, suggesting its limited
involvement in invasion and tissue damage. Interestingly, SAP
gene expression was not significantly different between
infecting and planktonic strains of C. tropicalis. Furthermore,
the effect of the aspartyl proteinase inhibitor, pepstatin A,
on the infection process was also evaluated to provide a
complementary insight into potential involvement of SAPs in
C. tropicalis invasion and damage to the RHOE. Pepstatin A is
a specific inhibitor of acidic proteinases and has been widely
used as an inhibitor of Candida aspartyl proteinase activity
[25,29,30]. Interestingly, treatment with pepstatin A did not
prevent tissue invasion or apparent histological damage
induced by C. tropicalis (Fig. 5). Furthermore, LDH activity
was also not reduced by incorporation of pepstatin A, rein-
forcing the view that the extent of tissue damage was main-
tained even when SAP activity was inhibited. It would appear
therefore that SAPs do not play a significant role in tissue
invasion and damage caused by C. tropicalis. These results
appear to be in agreement with recent studies involving
C. albicans, which demonstrated that SAPs were not required
for invasion [30], and damage to RHOE [29].
In summary, the present study confirms the effectiveness
of RHOE as an in vitro model to study Candida virulence
attributes and broadens our knowledge on C. tropicalis viru-
lence mechanisms. The CLSM approach has conclusively
shown that C. tropicalis was not only capable of colonizing,
but also could invade RHOE, leading to significant damage in
the tissue structure. Furthermore, to our knowledge, this is
the first report of C. tropicalis SAPT gene expression during
tissue invasion, and the results obtained imply a limited role
of these enzymes in C. tropicalis invasion and tissue damage.
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aMean arbitrary messenger RNA transcript levels based upon triplicate measurements, presented as a percentage relative to the respective ACT1 transcript level.
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